论文部分内容阅读
Ⅲ期胃癌根治术后599例随机分成两组。介入化疗组采用MFA方案；对照组（非介入化疗组）采用静脉化疗（采用MF方案）或口服化疗（用FT-207），观察二组1、3、5、7年生存率，结果发现，介入化疗组的生存率显著高于非介入化疗组（P＜0．05）。说明介入化疗可提高Ⅲ期胃癌的生存率。
After radical resection of stage III gastric cancer, 599 patients were randomly divided into two groups. The interventional chemotherapy group was treated with MFA. The control group (non-invasive chemotherapy group) was treated with intravenous chemotherapy (using the MF protocol) or oral chemotherapy (using FT-207). The survival rates of the two groups at 1, 3, 5, and 7 years were observed. The survival rate in the interventional chemotherapy group was significantly higher than that in the non-invasive chemotherapy group (P<0.05). This shows that interventional chemotherapy can improve the survival rate of stage III gastric cancer.